FDA Greenlights Vyloy for Gastric Cancer, Egypt Achieves Malaria-Free Status

The FDA has approved Astellas' Vyloy to treat gastric cancer. Egypt has been certified malaria-free by WHO. A Tennessee court temporarily blocked parts of the state's abortion ban. Sanofi plans to sell stakes in Opella. Cigna and Humana have resumed merger talks.

The FDA has given the nod to Astellas' Vyloy, a new therapy for gastric cancer, indicating significant advancements in cancer treatment. The therapy will be used alongside chemotherapy to combat cancer in the gastroesophageal junction.

Egypt has reached a public health milestone as the World Health Organization certifies the country malaria-free. This historical move ends a long battle against the disease that dates back to ancient times.

In legal news, a Tennessee court has issued a temporary halt on parts of the state's abortion ban pertaining to certain emergency medical conditions, amid ongoing lawsuits from affected doctors and women.

(With inputs from agencies.)